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Gougerotin, a peptidyl nucleoside antibiotic, pos-
sesses antitumor, antiviral, antibacterial, antimy-
coplasma, anthelmintic, and acaricidal activities.
Here, we report the cloning of a complete gougerotin
biosynthetic gene cluster from Streptomyces grami-
nearus and heterologous production of gougerotin
in Streptomyces coelicolor. Sequence analysis of
a 28.7 kb DNA fragment indicated that the cluster
consists of 25 open reading frames (ORFs). Gene
disruption and genetic complementation experi-
ments revealed that 15 of the 25 ORFs are required
for gougerotin biosynthesis. A gougerotin biosyn-
thetic pathway was proposed based on the ana-
lyses of bioinformatics and intermediates accumu-
lated in selected gene inactivation mutants. These
studies substantially promoted our understanding
of gougerotin biosynthesis and provide ‘‘building
blocks’’ for combinatorial biosynthesis using genes
encoding different enzymes in nucleoside anti-
biotics.
INTRODUCTION
The peptidyl nucleoside antibiotics are a group of important
microbial secondary metabolites with a broad spectrum of bio-
logical activities. Gougerotin, also known as aspiculamycin or
asteromycin, is a peptidyl nucleoside antibiotic produced by
Streptomyces gougerotii (Iwasaki, 1962), Streptomyces toyo-
caensis var. aspiculamyceticus (Arai et al., 1974), and Strepto-
myces S-514 (Ikeuchi et al., 1972). Gougerotin has been found
to be a specific inhibitor of protein synthesis (Clark and Gunther,
1963). It has been shown to inhibit selectively the incorporation
of amino acids into protein by binding ribosomal peptidyl trans-
ferase (Casjens and Morris, 1965; Cerna´ et al., 1971). The inter-
action of gougerotin with peptidyl transferase disturbs the
relative positioning of the 30 end of the P/P0 site-bound tRNA
and the peptidyl transferase loop region of 23S rRNA (Kirillov
et al., 1999). This mode of action affords gougerotin versatile
bioactive properties, and it is reported to possess antibacterial,
anthelmintic, acaricidal, antimycoplasma, antiviral, and anti-34 Chemistry & Biology 20, 34–44, January 24, 2013 ª2013 Elseviertumor activities (Haneishi et al., 1974; Kondo et al., 1974; Lacal
et al., 1980).
The peptidyl nucleoside antibiotics are generated from
simple nucleoside and amino acid building blocks. Most
members of this family of antibiotics are consisted of three
distinct structural components: a heterocyclic base, an amino
sugar appendage, and an unusual amino acid or peptidyl
moiety (Cone et al., 2003). Gougerotin consists of cytosine,
4-amino-4-deoxyglucuronamide, and a sarcosyl-D-serine di-
peptide (Figure 1A). Cytosine and 4-amino-4-deoxyglucurona-
mide constitute the nucleoside skeleton (Fox et al., 1968),
which resembles cytosylglucuronic acid (CGA) intermediate in
blasticidin S biosynthesis (Cone et al., 2003). Gougerotin is
a stereoisomer of ningnanmycin, a plant virucide commercially
available in China (Wang et al., 2010). The only difference
between these two antibiotics is that ningnanmycin contains
L-serine, and gougerotin contains D-serine in the dipeptide
moiety (Figure 1A).
Biosynthetic pathways for some of peptidyl nucleoside antibi-
otics have been extensively studied in the past decades. The
biosynthetic gene clusters were identified for the adenine deriv-
ative puromycin (Lacalle et al., 1992; Tercero et al., 1996), the
cytosine derivative blasticidin S (Cone et al., 2003), mildiomycin
(Li et al., 2008), as well as uridine-based nikkomycin and
polyoxin (Chen et al., 2009; Liu et al., 2005). Previous studies
of gougerotin have focused on its mechanism of action, bio-
logical activities, and chemical synthesis (Clark and Gunther,
1963; Fox and Watanabe, 1971; Haneishi et al., 1974; Kirillov
et al., 1999; Kondo et al., 1974; Lacal et al., 1980; Lichtenthaler
et al., 1971; Migawa et al., 2005; Watanabe et al., 1972). How-
ever, to our knowledge, nothing is known about the gougerotin
biosynthesis. To understand the biosynthesis of gougerotin,
we cloned the complete gougerotin biosynthetic gene cluster
from S. graminearus, a gougerotin-producing strain deposited
as CGMCC 4.506 at China General Microbiological Culture
Collection (CGMCC). The heterologous production of gougero-
tin in the well-characterized surrogate S. coelicolor helped us to
determine the border of gene cluster for gougerotin biosyn-
thesis. Bioinformatics and functional analyses of open reading
frames (ORFs) in the gene cluster led to a proposed gougerotin
biosynthetic pathway. This study provides significant insight
into the biosynthesis of gougerotin. It will also pave the way
for the generation of hybrid peptidyl nucleoside antibiotics as
exemplified by two recent studies (Li et al., 2011; Zhai et al.,
2012).Ltd All rights reserved
Figure 1. Identification of Gougerotin from
S. graminearus
(A) Chemical structures of gougerotin, ningnan-
mycin, and blasticidin S.
(B) HPLC analysis of the metabolites produced by
S. graminearus.
(C) MS/MS analysis of the metabolites produced
by S. graminearus.
1: gougerotin, [M+H]+ = 444.2 (exact mass =
443.18); 2: yunnanmycin, [M+H]+ = 445.2 (exact
mass = 444.16); 5: CGA, [M+H]+ = 288.1 (exact
mass = 287.08). The fragmentation patterns of
the parent ions are shown, and the peaks corre-
sponding to the characteristic fragments are
labeled.
See also Figure S1.
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Identification of Gougerotin from S. graminearus
Gougerotin was previously isolated from several Streptomyces
by Arai et al. (1974), Ikeuchi et al. (1972) and Iwasaki (1962).
In this study, culture filtrate of S. graminearus, a gougerotin
producer deposited as CGMCC 4.506 at CGMCC, was exam-
ined by HPLC analysis. Three distinct peaks were identified (Fig-
ure 1B). Isolated compound 1was first analyzed by electrospray
ionization mass spectrometry (ESI-MS). ESI-MS analysis of 1
revealed an [M+H]+ ion at m/z 444.2 (exact mass = 443.4), and
the MS/MS spectrum revealed the fragmentation pattern con-
sistent with that for gougerotin (Figure 1C). The structure of 1
was finally validated by NMR analysis (Figure S1 available on-
line). From the NMR spectra, we noticed two sets of signals
for 16-CH, 19-CH, 21-CH, 13-NH, and 17-NH (Figure S1). We
speculate the coexistence of its stereoisomer (ningnanmycin)
with gougerotin. In order to test this possibility, purified com-
pound 1 was subjected to acid hydrolysis and following deriva-
tization with o-phthaldialdehyde (OPA) and N-acetyl-L-cysteine
(NAC) (Figures S3A and S3B). The presence of both D-serine
and L-serine was confirmed after HPLC separation of D- and
L-serine derivatives (Figure S3C). Ningnanmycin may be gener-
ated as an intermediate of gougerotin biosynthesis or from
the racemization of gougerotin during the sample handling pro-
cess. In addition, we also detected CGA (5) (Figures 1B, 1C, and
S2; Table S1) and a minor metabolite yunnanmycin (2) (Figures
1B and 1C) (Chen et al., 1998), which may be from the accumu-
lated intermediate of gougerotin production due to incomplete
biotransformation.Chemistry & Biology 20, 34–44, January 24, 201Cloning andCharacterization of the
Gougerotin Gene Cluster
Based on the observation that gougerotin
and blasticidin S share similar nucleoside
skeleton (Figure 1A), we speculated that
4-amino-glucuronamide nucleoside skel-
eton of gougerotin is a derivative of CGA.
In blasticidin S biosynthesis, CGA syn-
thase (encoded by blsD) catalyzes the
condensation of cytosine and UDP-glu-
curonic acid to form CGA (Gould and
Guo, 1994). By searching the genomesequence of S. graminearus generated from 454 sequencing
(unpublished data), we identified a BlsD homolog (45% simi-
larity, 34% identity). This gene was then used as a probe to clone
the entire gougerotin biosynthetic gene cluster from a fosmid
library consisting of8,000 clones from S. graminearus genomic
DNA. PCR screening of the library with the blsD homologous
gene primers (gouF-F and gouF-R) revealed 5 positive clones
from 2,000 fosmid clones. Among them, fosmid D6-4H and
D6-9F are overlapping and span40 kb contiguous region as re-
vealed by end-sequencing and alignment with the genome
sequence of S. graminearus. Further analysis of fosmid D6-4H
shows that it contains a 28.7 kb insert (GenBank accession
number JQ307220) with an overall G+C content of 72.70%.
The FramePlot 4.0beta online program revealed the organization
of the cluster consisting of 25 complete ORFs (Figure 2), and the
deduced functions of genes in this cluster are listed in Table 1.
To test whether the 28.7 kb contiguous DNA fragment is
responsible for gougerotin biosynthesis, we set out to inactivate
the gouH and gouL by targeted double-crossover recombination
in S. graminearus. Culture filtrate from the resulting gouH and
gouL inactivation mutants was subjected to HPLC analysis.
Unlike culture filtrate from S. graminearus wild-type strain,
which shows a distinct gougerotin peak with a retention time at
6.4 min, culture filtrates from gouH and gouL inactivation
mutants lack this peak (Figure 3). Because gouH and gouL
are within a group of 12 genes that might form an operon,
inactivation of downstream genes by polar effects on transcrip-
tion might have contributed to the phenotype observed. To
exclude this possibility, we selected the upstream gouL gene
for genetic complementation experiments. Complementation3 ª2013 Elsevier Ltd All rights reserved 35
Figure 2. Organization of the Gougerotin Biosynthetic Gene Cluster
in Fosmid D6-4H
The gene cluster spans 28.7 kb fragment and contains 25 ORFs. Genes are
indicated by different arrowheads according to their proposed roles.
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of constitutive hrdB promoter restored the production of gouger-
otin (Figure 3). These results show that the gene cluster we
cloned is indeed involved in gougerotin biosynthesis.
Heterologous Production of Gougerotin in S. coelicolor
To test whether D6-4H contains all genes required for gougerotin
biosynthesis, the insert of 28.7 kb was cloned into pSET152,
and the resulting recombinant plasmid pSET152::D6-4H (Fig-
ure S4A) was first introduced into S. coelicolorM145 to generate
M145-D6-4H. Gougerotin was detected in the culture filtrate of
M145-D6-4H. However, the peak of gougerotin was interfered
by surrounding peaks from the host (data not shown). We then
chose the engineered S. coelicolor M1146 as a heterologous
host in which four endogenous secondary metabolite gene clus-
ters were deleted (Gomez-Escribano and Bibb, 2011). Culture
filtrate from M1146-D6-4H was subjected to HPLC analysis,
and a distinct peak with a retention time of 6.4 min appeared,
whereas the culture filtrates from the negative control strains
(S. coelicolor M1146 and S. coelicolor M1146-pSET152) lack
this peak (Figure 4A). To further confirm that the peak from the re-
combinant strain was indeed gougerotin, we performed the MS/
MS analysis in a positive ion mode, which revealed a distinct ion
and fragmentation pattern that matches exactly to the pattern of
the peak fromS. graminearuswild-type (Figure 4B). These results
definitively demonstrated that we have successfully cloned the
complete gene cluster for gougerotin biosynthesis, which is
sufficient for heterologous production in the surrogate host.
Boundaries of theGougerotin BiosyntheticGeneCluster
In order to determine the minimal contiguous gene cluster
required for gougerotin production, deletion derivatives that
truncated the fosmid D6-4H from both sides of the 28.7 kb insert
were constructed (Figures S4B and S4C) and transferred into S.
coelicolor M1146. The effects of these deletions on gougerotin
production were monitored by HPLC analysis. On the left-hand
side, a recombinant strain, BDorf(1)–(6) lacking ORFs(6)–
(1), still produced gougerotin (Figure 4C). gouR, encoding
a putative TetR family regulatory protein, is the only gene with
potential regulatory function in the cluster. A separate study
shows that gouR plays a regulatory role in gougerotin biosyn-
thesis (unpublished data). Thus, we propose that gouR is at36 Chemistry & Biology 20, 34–44, January 24, 2013 ª2013 Elsevierthe left boundary of the gougerotin biosynthetic gene cluster.
On the right-hand side, the strain, BDorf1–4 with the deletions
of ORFs1–4, continued to produce gougerotin, whereas another
strain, BDgouN, in which gouN was removed in addition to
ORFs1–4, abolished gougerotin production (Figure 4C). These
experiments suggest that the minimum gougerotin biosynthetic
gene cluster contains 15 genes, from gouR to gouN, spanning
a contiguous DNA fragment of 17 kb. This DNA fragment is
sufficient to confer gougerotin production in S. coelicolor
M1146. Bioinformatics analysis, consisting of BLAST searches
followed by alignment to representative proteins and identifica-
tion of conserved active site residues, allowed us to assign
potential functions to each ORF (Table 1).
Biosynthesis of Nucleoside Skeleton
Four genes, gouA, gouB, gouF, and gouH, are putatively in-
volved in the biosynthesis of the nucleoside moiety of gougero-
tin. As mentioned above, gougerotin and blasticidin S share
similar nucleoside skeleton. In blasticidin S biosynthesis, CGA
is the earliest committed intermediate. CGA synthase (encoded
by blsD) catalyzes the condensation of UDP-glucuronic acid and
cytosine (Gould and Guo, 1994). The presence of CGA in the
culture supernatant of S. graminearus (Figures 1B and 1C) indi-
cated that CGA is also an intermediate in gougerotin biosyn-
thesis. By blasting with the GenBank database, GouF is found
to exhibit 34% identity with the BlsD from the biosynthetic
pathway of blasticidin S (Cone et al., 2003). It also exhibits
28% identity with the AmiJ, which is proposed to catalyze the
coupling of amicetose and cytosine to form an N-glycosidic
bond in amicetin biosynthesis (Zhang et al., 2012). Thus, GouF
possibly catalyzes the coupling of UDP-glucuronic acid and
cytosine to form CGA in gougerotin biosynthesis. To test this
hypothesis in vivo, gouF mutant cluster was constructed and
then introduced into S. coelicolor M1146 to generate gouF-
IFD, CGA formation and gougerotin production were completely
abolished, and cytosine was accumulated substantially in the
gouF-IFD strain, which is verified by the coinjection of super-
natant from gouF-IFD strain with cytosine standard (Fig-
ure 5A). GouA exhibits high identity to various putative oxidore-
ductases, such as the putative oxidoreductase (CAJ89749.1,
88% identity) from Streptomyces ambofaciens ATCC 23877.
GouA has the D-arabinose dehydrogenase-like domain and
potential NAD-binding sites, substrate-binding sites, and Zn-
binding sites. Therefore, GouA may oxidize CGA at C-4 of glu-
curonic acid, and the resulting 4-carbonyl-CGA could serve as
a substrate for amination catalyzed by GouH to form 4-amino-
CGA. GouH, a DegT/DnrJ/EryC1/StrS aminotransferase with
pyridoxal-phosphate as the coenzyme, displays 33% (122 of
372) identity to BlsH, which is predicted to function in the amino
deoxynucleoside formation in the biosynthesis of blasticidin S
(Cone et al., 2003). In the resulting gouH inactivation mutant of
S. graminearus, gougerotin was not produced, and CGA instead
of its predicted substrate of 4-carbonyl-CGA was accumulated
(Figure 3). The same result was observed with the gouH in-frame
deletion mutant in S. coelicolor M1146 (Figure 5A). This can be
explained by the unstable property of 4-carbonyl-CGA. The
asparagine synthase (glutamine hydrolyzing) encoded by gouB
may be responsible for the amidation of yunnanmycin at C-6 of
glucuronic acid (Figure 6).Ltd All rights reserved
Table 1. Summary of Fosmid D6-4H ORFs
ORF
No. of
Amino Acids Proposed Function Protein Homologya
Amino Acid
Identity (%)
orf(6) 117 Streptomyces zinciresistens K42 hypothetical protein SZN_16877
(ZP_08804424)
42/114 (37)
orf(5) 132 Streptomyces pristinaespiralis ATCC 25486 predicted protein
(ZP_06913373)
88/125 (70)
orf(4) 307 Streptomyces cattleya NRRL 8057 = DSM 46488 phosphatidylserine/
phosphatidylglycerophosphate/cardiolipin synthase-like protein
(AEW98033)
164/280 (59)
orf(3) 500 Streptosporangium roseum DSM 43021 major facilitator superfamily
MFS_1 (ACZ86657)
408/500 (82)
orf(2) 123 Streptomyces cattleya NRRL 8057 = DSM 46488 YCII-related protein
(AEW99749)
104/123 (85)
orf(1) 403 Frankia sp. EUN1f putative RNA polymerase, sigma-24 subunit,
ECF subfamily (ZP_06415013)
342/402 (85)
gouR 228 Transcriptional regulator Streptomyces ambofaciens ATCC 23877 putative TetR-family
transcriptional regulator (CAJ89747)
153/204 (75)
gouA 346 CGA oxidase Streptomyces ambofaciens ATCC 23877 putative oxidoreductase
(CAJ89749)
303/346 (88)
gouB 595 Amidase Cytophaga hutchinsonii ATCC 33406 asparagine synthase (ABG60840) 161/552 (29)
gouC 433 Unknown Streptomyces sp. SPB74 conserved hypothetical protein (EDY43555) 129/467 (28)
gouD 315 Unknown Streptomyces ghanaensis ATCC 14672 glycosyltransferase (EFE71578) 128/290 (44)
gouE 246 Unknown Planctomyces brasiliensis DSM 5305 Conserved hypothetical protein
CHP00730 (ADY58906)
73/182 (40)
gouF 397 CGA synthase Streptomyces griseochromogenes CGA synthase (AAP03118) 75/222 (34)
gouG 388 Phosphoglycerate mutase Moorella thermoacetica ATCC 39073 phosphoglycerate mutase
(ABC19419)
62/193 (32)
gouH 386 Aminotransferase Methanospirillum hungatei JF-1 DegT/DnrJ/EryC1/StrS
aminotransferase (ABD41833)
102/344 (30)
gouI 311 Aminotransferase Synechococcus sp. WH 5701 perosamine synthetase (ZP_01083876) 64/142 (45)
gouJ 372 Acyl-CoA N-acyltransferase Bradyrhizobium sp. ORS 278 putative Acyl-CoA N-acyltransferase
(CAL78697)
50/164 (30)
gouK 224 Acyl-CoA synthetase Clostridium botulinum A3 str. Loch Maree CoA-binding domain protein
(ACA54930)
45/227 (20)
gouL 269 2-Aminomalonate
semialdehyde oxidase
Pseudomonas syringae pv. syringae FF5 3-hydroxyisobutyrate
dehydrogenase (ZP_06495709)
77/218 (35)
gouM 442 Transporter Anabaena variabilis ATCC 29413 major facilitator superfamily MFS_1
(ABA25090)
49/157 (31)
gouN 239 Glycine N-methyltransferase Microcoleus chthonoplastes PCC 7420 Methyltransferase domain family
(EDX77140)
58/187 (31)
orf1 734 Streptomyces roseosporus NRRL 11379 peroxidase/catalase
(EFE72825)
639/733 (87)
orf2 130 Aspergillus clavatus NRRL 1 dynactin, putative (EAW14193) 30/89 (34)
orf3 138 Streptomyces sp. SirexAA-E ferric uptake regulator, Fur family
(AEN12271)
119/136 (88)
orf4 380 Streptomyces clavuligerus ATCC 27064 truncated integral membrane
protein (EDY49466)
196/346 (57)
The percentage of homology presented is based on overall homology.
aResults generated by BLAST analysis of deduced ORFs are presented. Accession numbers are listed in parentheses.
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The peptidyl moiety of gougerotin consists of a sarcosyl-D-
serine dipeptide that most likely comes from serine and sarco-
sine. Three genes (gouG, gouI, and gouL) are predicted to
participate in the de novo biosynthesis of serine. A putativeChemistry & Biology 20,phosphoglycerate mutase encoded by gouG is responsible for
the conversion of 3-phosphoglycerate (3PG) to 2-phosphoglyc-
erate (2PG) through a 2,3-bisphosphoglycerate intermediate.
GouI shows 45% identity to a perosamine synthetase (ZP_
01083876.1) from Synechococcus sp. WH 5701 and may be34–44, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 37
Figure 3. HPLC Analysis of Gougerotin
Produced by S. graminearus and Its
Derivatives
(A) HPLC analysis of gougerotin production in
gouH mutant, gouL mutant, and gouL comple-
mentation strain. SgrWT, supernatant collected
from S. graminearus wild-type; gouHDM, super-
natant collected from S. graminearus gouH inac-
tivation mutant; gouLDM, supernatant collected
from S. graminearus gouL inactivation mutant;
gouLc, supernatant collected from S. graminearus
gouL complementation strains. 1, gougerotin; 4,
4-amino CGA; 5, CGA.
(B) MS/MS analysis of the intermediate 4 accu-
mulated in the gouL mutant.
See also Figure S2.
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which can putatively be oxidized to serine by GouL. GouL is
homologous to many 3-hydroxyisobutyrate dehydrogenases,
which could catalyze not only the oxidation of 3-hydroxyisobuty-
rate but also L-serine, D-threonine, and other 3-hydroxyacid
derivates (Yao et al., 2010). Inactivation of gouL resulted in
the accumulation of compound 4 with [M+H]+ = 287.1 (exact
mass = 286.09) (Figure 3). MS/MS analysis showed that this
compound is 4-amino-CGA, lacking the dipepetide compared
with yunnanmycin (Figure 3). Sarcosine (N-methyl-glycine) is
generated from glycine by glycine N-methyltransferase (Velich-
kova and Himo, 2005). In actinomycin biosynthesis, glycine
was first methylated to form sarcosine, which is then incorpo-
rated into the actinomycin peptide backbone (Fukagawa et al.,
1974). GouN carries a methyltransferase domain and is probably
involved in the methylation of glycine to form sarcosine. This is
verified by the accumulation of a compound 3 with [M+H]+ =
374.1 (exact mass = 373.12), lacking sarcosine compared with
yunnanmycin (2) in the BDgouN strain (Figures 4C and 5B). We
also tried feeding different concentrations of D- and L-serine
into gouL mutant culture or sarcosine into gouN mutant culture,
but no restoration of gougerotin production was observed.
When serine and sarcosine are ready, they need to be incorpo-
rated into the nucleoside skeleton to form an active gougerotin.
There are two possible ways for the incorporation of serine and
sarcosine. First, serine and sarcosine residues can be sequen-
tially attached to the nucleoside skeleton. Second, serine and
sarcosine are condensed to form the sarcosyl-serine dipeptide,
which is then attached to the nucleoside skeleton. The accumu-
lation of compound 3 in the gouN mutant indicated that the
nucleoside moiety is coupled with serine at first and then sarco-
sine is attached to the seryl-nucleoside moiety skeleton.
The incorporation step may require the participation of
gouJ and gouK. GouK shows 20% identity and 37% simi-
larity to coenzyme A (CoA)-binding domain-containing protein38 Chemistry & Biology 20, 34–44, January 24, 2013 ª2013 Elsevier Ltd All rights reserved(YP_001788025.1) from Clostridium
botulinum (strain Loch Maree/Type A3).
Although the N terminus of GouJ contains
a conserved NAT_SF domain for N-ace-
tyltransferase superfamily enzymes and
displays homologous to acyl-CoA N-
acyltransferase (YP_001206914.1, 30%identity, 41% similarity) from Bradyrhizobium sp. ORS 278,
N-acetyltransferases can transfer the acetyl group from acetyl
CoA to a primary amine (Dyda et al., 2000). Therefore, we spec-
ulate that GouK can activate the serine or glycine to form seryl-
CoA or sarcosyl-CoA, and GouJ can then catalyze the transfer
of the seryl and sarcosyl group from acyl-CoA to the amino group
of nucleoside moiety. In gouK mutant (gouK-IFD), gougerotin
was not produced, and we found a peak of compound 4 with
[M+H]+ = 287.1 (exact mass = 286.09) (Figure 5A). MS/MS anal-
ysis showed that this compound is 4-amino-CGA (Figure 5C).
This is consistent with the involvement of GouK in the condensa-
tion of nucleoside moiety and peptidyl group.
Regulation and Secretion
One candidate regulatory gene, gouR, was identified. It encodes
a putative TetR family transcriptional regulator that is character-
ized by the N-terminal helix-turn-helix (HTH) DNA-binding
domain. TetR is a large family of transcriptional regulators, which
often serve as repressors and are widely distributed among bac-
teria, regulating a number of diverse processes (Ramos et al.,
2005; Routh et al., 2009). The detailed functions of this gene in
gougerotin biosynthesis will be addressed in a separate study.
Functioning as a specific inhibitor of protein synthesis, gou-
gerotin may be toxic to its producer. A simple way to avoid this
detrimental effect is the secretion of this compound outside of
the cell. The gouM gene encodes a protein homologous to
permease of the major facilitator superfamily (MFS). MFS trans-
porters comprise a large and diverse group of membrane
proteins that facilitate the transport of a variety of substrates
across cytoplasm or internal membranes (Law et al., 2008).
The MFS transporters are single polypeptide carriers that are
only capable of transporting small molecules by using energy
from electrochemical gradients across membranes. This is dif-
ferent from themost commonATP-binding cassette (ABC) trans-
porters, which are generally multicomponent proteins capable of
Figure 4. Heterologous Expression of Gou-
gerotin and Boundary Determination
(A) Heterologous expression of gougerotin in
S. coelicolor M1146.
(B) MS/MS analysis of gougerotin produced by
S. coelicolor M1146-D6-4H.
(C) HPLC analysis of gougerotin produced by
mutants for boundary determination. M1146-
D6-4H, supernatant collected from S. coelicolor
M1146 containing pSET152::D6-4H; M1146,
supernatant collected from S. coelicolor M1146;
M1146-pSET152, supernatant collected from
S. coelicolor M1146 containing pSET152; BDorf
(1)–(6), supernatant collected from mutant
lacking ORFs(6)–(1); BDgouN supernatant
collected frommutant lacking gouN andORFs1–4;
BDorf1–4, supernatant collected from mutant
lacking ORFs1–4. 1, gougerotin; 3, compound 3;
5, CGA.
See also Figure S4.
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expense of ATP hydrolysis (Martı´n et al., 2005). Like GriC from
griseobactin cluster (Patzer and Braun, 2010) and HomH from
holomycin cluster (Huang et al., 2011), GouM can potentially
export gougerotin from the cytoplasm into the medium.
Genes with Unknown Functions
Finally, the functions of three genes are not assigned. gouD
encodes a glycosyltransferase and shows 44% identity to
ZP_06581117.1 from Streptomyces ghanaensis ATCC 14672,
42% identity to NP_822010.1 from Streptomyces avermitilis
MA-4680. The deduced products of gouC and gouE exhibit
sequence similarity to hypothetical protein (ZP_06827477.1,
28% identity) from Streptomyces sp. SPB74 and Plabr_
1294(YP_004268928.1, 40% identity) from Planctomyces brasi-
liensis DSM 5305, respectively. More genetic and biochemical
studies are needed to clarify the exact functions of these genes.
DISCUSSION
Gougerotin is a peptidyl nucleoside antibiotic with broad biolog-
ical activities. In this study, the gene cluster for gougerotin
biosynthesis was cloned. This is based on the observation that
4-amino-glucuronamide nucleoside skeleton of gougerotin is
very similar to the CGA intermediate in blasticidin S biosyn-
thesis. An amide group was present in 4-amino-glucuronamide
instead of carboxyl group in CGA. In blasticidin S biosynthesis,
CGA synthase encoded by blsD is responsible for the con-
densation of cytosine and UDP-glucuronic acid to form CGA
(Gould and Guo, 1994). By searching the sequenced genome
of S. graminearus, we identified GouF as a homolog of BlsD.
We initially cloned a 28.7 kb DNA fragment that covers all genes
required for gougerotin biosynthesis. This is demonstrated by
the successful production of gougerotin in the heterologous
host S. coelicolor M1146. The boundary of the gene cluster
was determined by generating mutants with truncations fromChemistry & Biology 20, 34–44, January 24, 201both sides of the 28.7 kb contiguous
region. The minimized gene cluster
consists of 15 genes: 13 of them encodeenzymes responsible for gougerotin biosynthesis, 1 encodes
a putative pathway-specific regulatory protein, and the other
one encodes a potential gougerotin secretion protein. Bio-
informatics analysis and the identification of intermediates accu-
mulated in specific gene inactivation mutants led to a proposed
biosynthetic pathway of gougerotin (Figure 6). Cytosine (6) is
first coupled with UDP-glucuronic acid to form CGA (5), then
CGA is oxidized and aminated to obtain 4-amino-CGA (4).
Next, activated serine and sarcosine are sequentially attached
to 4-amino-CGA to form yunnanmycin (2). Final generation of
gougerotin (1) was achieved after the amidation of yunnanmycin
at C-6 of glucuronic acid.
The first step proposed in the pathway requires UDP-glucur-
onic acid and cytosine. UDP-glucuronic acid was suggested
to originate from the primary precursor glucose in blasticidin
S biosynthesis (Cone et al., 2003). Cytosine is proposed to
be generated from the hydrolysis of cytidine monophosphate
(CMP) by CMP hydrolase. Homologs of the CMP hydrolase
were identified in blasticidin S, mildiomycin, and amicetin bio-
synthetic gene clusters (Cone et al., 2003; Li et al., 2008; Zhang
et al., 2012). Constitutive expression of blsM, the gene encoding
the CMP hydrolase in blasticidin S cluster, in S. lividans TK24
led to 20- to 27-fold increase of cytosine levels over the wild-
type S. lividans TK24 (Cone et al., 2003). The CMP hydrolysis
activity of MilB frommildiomycin gene cluster was demonstrated
in vitro, and the milB disruption mutant abolished mildiomycin
production (Li et al., 2008). Likewise, the inactivation mutant of
CMP hydrolase gene (amiI) in S. vinaceusdrappus NRRL 2363
lost the ability to produce amicetin, and the complementation
strain could partially restore the production of amicetin (Zhang
et al., 2012). In the biosynthetic pathway of these three com-
pounds, CMP hydrolase is responsible for the hydrolysis of
CMP to provide cytosine for the following coupling reactions.
Although a CMP hydrolase-coding gene was located at a
locus apart from the gougerotin cluster on the chromosome of
S. graminearus, the gougerotin biosynthetic gene cluster alone3 ª2013 Elsevier Ltd All rights reserved 39
Figure 5. Intermediates Accumulation in
Selected Mutants
(A) HPLC analysis of intermediates accumulated in
gouF, gouH, and gouK in-frame deletion mutants.
(B) MS/MS analysis of the intermediate 3 accu-
mulated in the BDgouN strain.
(C) MS/MS analysis of the intermediate 4 accu-
mulated in the gouK in-frame deletion mutant.
M1146-D6-4H, supernatant collected from
S. coelicolor M1146 containing pSET152::D6-4H;
gouH-IFD, supernatant collected from gouH in-
frame deletion mutant; gouF-IFD, supernatant
collected from gouF in-frame deletion mutant;
cytosine, cytosine standard (0.25 mg/ml); gouK-
IFD, supernatant collected from gouK in-frame
deletion mutant; 1, gougerotin; 3, compound 3; 4,
4-amino CGA; 5, CGA; 6, cytosine. The fragmen-
tationpatternsof theparent ionsareshown,and the
peaks corresponding to the characteristic frag-
ments are labeled.
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The absence of CMP hydrolase gene in gougerotin cluster indi-
cated that cellular cytosine is directly used for coupling with
UDP-glucuronic acid.
The appearance of D-amino acid residues is widespread in
natural peptide antibiotics (Martı´nez-Rodrı´guez et al., 2010).
However, the presence of D-amino acid in peptidyl nucleoside
antibiotic is not common. Base on sequence analysis, gouG,
gouI, and gouL are suggested to be responsible for the de
novo biosynthesis of serine. However, two questions need to
be answered before the elucidation of steps involved in serine
biosynthesis.
(1) Are these three genes sufficient for the formation of
D-serine, or are other genes within or outside the gou-
gerotin cluster involved? In ribosomally synthesized poly-
peptide antibiotics, the conversion of L-amino acid to
D-amino acid results from a two-step reaction involving
a lantibiotic synthetase and a dehydrogenase (Cotter
et al., 2005), whereas the epimerization domain of nonri-
bosomal peptide synthetases (NRPSs) is responsible for
the conversion of L-amino acid to D-amino acid in nonri-
bosomal peptide antibiotics (Li and Jensen, 2008; Stein
et al., 2005).
(2) Does the conversion of L-serine to D-serine occur before
or after the incorporation into the nucleoside skeleton?
The conversion of L-amino acid to D-amino acid occurred
after translation in peptide antibiotics (Cotter et al., 2005),
whereas the conversion was accomplished along with the40 Chemistry & Biology 20, 34–44, January 24, 2013 ª2013 Elsevier Ltd All rights reservedextending chain in nonribosomal
peptide antibiotics (Li and Jensen,
2008; Stein et al., 2005). Substitu-
tion of L-amino acid with D-amino
acid in antibiotics can change their
physical properties (Molhoek et al.,
2011) and antimicrobial activities
(Cotter et al., 2005; Kawai et al.,
2004). D-serine is presented inthe structure of gougerotin, whereas L-serine is found in
ningnanmycin. The existence of D-type or L-type serine
in gougerotin and ningnanmycin suggests that they may
differ in both physical features and biological activities.
Assembly of the nucleoside and peptidyl moieties with peptide
bond is one of the unique features of peptidyl nucleoside antibi-
otics. In the case of gougerotin, the free amino acid substrates
are first activated by CoA-binding domain-containing protein
(GouK), and the activated seryl or sarcosyl groups were then
transferred by acyl-CoA N-acyltransferase (GouJ) from acyl-
CoA to the amino group of nucleoside moiety. The unsuccessful
feeding experiments with sarcosine suggested that sarcosyl-
CoA was formed in a two-step mechanism. Glycine was first
converted to glycyl-CoA by GouK and subsequently methylated
by GouN to generate sarcosyl-CoA (Figure 6). This is different
from the other peptidyl nucleoside antibiotics. In the biosyn-
thesis of nikkomycins, polyoxins, and blasticidin S, SanS and
its homologs (PolG and BlsI) are suggested to be responsible
for the peptide bond formation (Chen et al., 2009; Cone et al.,
2003; Li et al., 2011). SanS, PolG, and BlsI belong to the ATP-
grasp-fold superfamily of enzymes. Members of this superfamily
are characterized by the unique structure of their ATP-binding
site (ATP-grasp fold), and they catalyze the ATP-dependent
reaction of a carboxylic acid with a nucleophile via the formation
of an acylphosphate intermediate (Fawaz et al., 2011). For
puromycin, attachment of the tyrosine moiety to the nucleoside
skeleton is predicted to be mediated by Pur6, a protein that
shows low similarities with peptide synthetases and lacks an
Figure 6. Proposed Biosynthetic Pathway of Gougerotin in S. graminearus
The proteins assigned for the proposed catalytic reactions are indicated. The intermediates identified were also labeled numerically.
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Gougerotin BiosynthesisAMP-binding domain (Tercero et al., 1996). tRNA-dependent
peptide bond formation mediated by transferase was also re-
ported in biosynthesis of the pacidamycin group of pentapep-
tidyl nucleoside antibiotics (Zhang et al., 2011). Themechanisms
of peptide bond formation need to be studied further for the
elucidation of this group of important antibiotics.Chemistry & Biology 20,SIGNIFICANCE
Gougerotin, a specific inhibitor of protein synthesis, dis-
plays broad biological activities. However, to our knowl-
edge, we knew nothing about the gougerotin biosynthesis
prior to when this study was initiated. In this study, we34–44, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 41
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Gougerotin Biosynthesiscloned and characterized the gougerotin biosynthetic gene
cluster from S. graminearus. Our findings provided impor-
tant insights into the biosynthesis of gougerotin. The char-
acterization of the biosynthetic pathway indicated that free
cytosine was coupled with UDP-glucuronic acid and that
the nucleoside skeleton was joined with its two amino acid
substrates sequentially. This study opens up venues for
future development of compoundswith improved properties
and rational design of peptidyl nucleoside antibiotics
through combinatorial biosynthesis.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, Fosmids, Primers, and Culture Conditions
Bacterial strains, plasmids, and fosmids used in this study are listed in Table
S2, and primers are listed in Table S3. S. graminearus CGMCC 4.506,
S. coelicolor, and their derivatives were grown on MS agar or in YEME liquid
medium at 28C. E. coli Top10 was used as a general host for propagating
plasmids. E. coli BW25113 (pKD20) was used for construction of recombinant
plasmids via l-Red-mediated recombination technology. E. coli ET12567
(pUZ8002) was used as a host for transferring DNA from E. coli into Strepto-
myces by intergeneric conjugation. General approaches for E. coli or Strepto-
myces manipulations were performed according to standard methods by
Kieser et al. (2000) and Sambrook and Russell (2001). The final antibiotic
concentrations used for selection of E. coli were as follows: 100 mg/ml ampi-
cillin, 100 mg/ml apramycin, 100 mg/ml kanamycin, 12.5 mg/ml chloramphen-
icol, and 15 mg/ml tetracycline. The final antibiotic concentrations used
for selection of S. graminearus were as follows: 25 mg/ml nalidixic acid,
25 mg/ml thiostrepton, and 20 mg/ml erythromycin. The final antibiotic concen-
trations used for selection of S. coelicolor were as follows: 25 mg/ml nalidixic
acid and 50 mg/ml apramycin.
DNA Isolation, Manipulation, and Sequencing
DNA isolation and manipulation in E. coli and Streptomyces were carried out
according to standard methods by Kieser et al. (2000) and Sambrook and
Russell (2001). PCR amplifications were carried out on a Bio-Rad DNA Engine
Peltier Thermal Cycler using either Taq DNA polymerase or KOD plus DNA
polymerase. Primer synthesis and DNA sequencing were performed at the
Shanghai Invitrogen Biotech and Beijing Institute of Genomics, Chinese
Academy of Sciences.
Genomic Library Construction and Screening
The genomic library of S. graminearus was constructed in CopyControl
pCC1FOS according to the manufacturer’s instructions (catalog no.
CCFOS110; Epicenter Technologies). Primer pair gouF-F/R was used for
screening the fosmid library by PCR. The positive clones were identified in
96-well plates.
Sequence Analysis
The nucleotide sequence reported in this paper is available in the GenBank
database under accession number JQ307220. The ORFs were deduced
from the sequence with the FramePlot 4.0beta program (http://nocardia.nih.
go.jp/fp4). The corresponding deduced proteins were compared with other
known proteins in the databases by available BLAST methods (http://www.
ncbi.nlm.nih.gov/blast/).
Production, Isolation, and Analysis of Gougerotin
For gougerotin production, spore suspensions were inoculated in liquid YEME
and incubated for 48 hr as seed culture. A total of 5 ml seed culture was then
transferred into 50 ml fermentation medium (2% glucose, 1% soluble starch,
0.5% yeast extract, 0.5% peptone, 0.3% NaCl, 1% soya power) and incu-
bated with shaking (220 rpm) for an additional 4–5 days at 28C.
For gougerotin isolation, the culture broth of S. graminearus was centri-
fuged, and the pH of the supernatant was adjusted to 3.0 with oxalic acid.
Then it was boiled for 10 min and centrifuged. The supernatant was chromato-
graphed on a Dowexs 50WX2 (H+, 100–200 mesh; Sigma-Aldrich) column and42 Chemistry & Biology 20, 34–44, January 24, 2013 ª2013 Elsevierthen it was eluted with 0.3 N ammonia solution. The collected fractions were
detected using phosphotungstic acid as indicator, the samples with blue color
were further concentrated to a small volume in vacuo (below 40C), and imme-
diately adjusted pH to 4.5 with acetic acid. Then, 8 vol of 95% ethanol was
added. After leaving themixture at 4Covernight, the precipitatewas collected
by centrifugation. The dried powder was subsequently dissolved in water and
analyzed by HPLC. Separation of the gougerotin was achieved with Agilent
1100 HPLC system and ZORBAX SB-C18 column (5 mm, 9.2 3 250 mm).
HPLC conditions were as follows: 92% H2O (0.1% TCA) + 8% methanol,
flow rate = 1 ml/min, UV = 276 nm. The targeted fraction was collected and
lyophilized for further analysis. MS analysis and tandem mass spectrometry
analysis were carried out on Triple-Quadrupole LC-MS/MS (Agilent 1260/
6460) in positive mode.
For gougerotin analysis, the culture broth was centrifuged, and the super-
natant was analyzed by HPLC with Agilent 1100 HPLC system and ZORBAX
SB-C18 column (5 mm, 4.6 3 250 mm). HPLC conditions were as follows:
92% H2O (0.1% TCA) + 8% methanol, flow rate = 1ml/min, UV = 276 nm.
The targeted fraction was collected and lyophilized for further MS and
MS/MS analyses.
Heterologous Expression of Gougerotin Biosynthetic Cluster
For the heterologous production of gougerotin, pSET152::D6-4H was con-
structed to determine whether the 28.7 kb DNA fragment in fosmid D6-4H
contains all genes essential for gougerotin biosynthesis. Fosmid D6-4H
was introduced into E. coli BW25113/pKD20 by electroporation. Plasmid
pSET152 was linearized with EcoRV and introduced into E. coli BW25113/
pKD20 containing fosmid D6-4H. Homologous recombination occurred in
lacZa region and then pCC1FOS backbone of D6-4H was replaced with
pSET152 to generate recombinant plasmid pSET152::D6-4H (Figure S4A).
The resulting pSET152::D6-4H was respectively introduced into S. coelicolor
M145 and S. coelicolor M1146 by intergeneric conjugation and then the re-
combinant strains M145-D6-4H and M1146-D6-4H were obtained. The
authenticity of these recombinant strains was verified by PCR using gouR-
UF/UR, gouH-UF/UR, and orf1-VF/VR primer pairs.
Construction of Mutants
Several mutants were generated for analysis of gougerotin biosynthesis. Gene
replacements and gene deletionswere constructed in E. coliBW25113/pKD20
by using the l-Red-mediated recombination method. For the construction of
gouH and gouL inactivation mutant in S. graminearus, we first constructed
pSVgouH-TA and pKC1139EK::D6-4H (see the Supplemental Experimental
Procedures). A 6.4 kb DNA fragment containing the thiostrepton/apramycin-
resistance cassette and gouH-flanking sequences was excised from
pSVgouH-TA and used to replace gouH in pKC1139::D6-4H. A 2.4 kb DNA
fragment was amplified using primers gouL-DF/gouL-DR with pSV152TA as
template. The amplified fragment containing the thiostrepton/apramycin-
resistance cassette and gouL-flanking sequences was used to replace gouL
in pKC1139::D6-4H. After restriction digestion analysis and PCR verification,
the mutant cluster was electroporated into E. coli ET12567/pUZ8002 and
transferred into S. graminearus by intergeneric conjugation. Spores of trans-
formants were harvested, series diluted, and spread on MS agar containing
thiostrepton. After growing for 4 days at 37C, colonies were replicated on
MS agar plates containing thiostrepton or erythromycin. Double-crossover ex-
conjugants are erythromycin sensitive (Erms) and thiostrepton resistant (Tsrr).
Erms strains are then verified by PCR and Southern blot analysis.
For the construction of gouH in-frame deletion mutant in S. coelicolor, the
6.4 kb DNA fragment was used to generate pfosH-TA with the inactivation of
gouH in fosmid D6-4H. The thiostrepton/apramycin-resistance cassette is
flanked by FRT (Flippase recognition target) sites, which allows for excision
of the antibiotic cassette following expression of the FLP-recombinase (Flip-
pase recombination enzyme) in E. coli BT340. The pCC1FOS backbone of
the mutant clusters was then replaced with pSET152 to generate pSET152::
gouH-IFD.
To construct gouF and gouK in-frame deletion mutants in S. coelicolor, the
thiostrepton/apramycin- resistance cassette was amplified from pSV152TA
with gouF-DF/DR and gouK-DF/DR, respectively. The resulting cassettes
(F-tsr/aprR and K-tsr/aprR) were used to generate pfosF-TA and pfosK-TA after
the inactivation of gouF and gouK in fosmid D6-4H. pSET152::gouF-IFD andLtd All rights reserved
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a similar procedure of pSET152::gouH-IFD. After restriction digestion analy-
sis and PCR verification, pSET152::gouF-IFD, pSET152::gouH-IFD, and
pSET152::gouK-IFD were transferred into S. coelicolor M1146, and the re-
combinant strains gouF-IFD, gouH-IFD, and gouK-IFD were obtained.
Complementation of gouL Mutant
For complementation experiments, the constitutive hrdB promoter was used
to drive the expression of gouL. The hrdB promoter was amplified from
S. graminearus genomic DNA with primers hrdB-PF/hrdB-PR. The coding
region of gouL was amplified from fosmid D6-4H with primer pair gouL-CF/
gouL-CR. The hrdB promoter was cut with XbaI, and the gouL-coding region
was cut with EcoRI. Both the hrdB promoter and gouL-coding fragment were
ligated together with XbaI/EcoRI double-digested pSET152Erm. The resulting
pSET152::gouLc was introduced into the gouL mutant to obtain the comple-
mentation strain gouLc.
Determination of theMinimal Gougerotin Biosynthetic Gene Cluster
In order to determine the boundaries of gougerotin biosynthetic gene cluster,
a series of truncation constructs (pD64H-R, pD64H-1, and pD64H-N) were
generated (described in detail in Figures S4B and S4C and the Supplemental
Experimental Procedures). The resulting constructs were verified by restriction
digestion and then transferred intoS. coelicolorM1146 to generate BDorf(1)–
(6), BDgouN and BDorf1–4 strains. The boundaries of gougerotin gene
cluster were determined by monitoring gougerotin production with HPLC
analysis.
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